Cargando…
Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases
Pulmonary vascular endothelial cells (VECs) are the main damaged cells in the pathogenesis of various respiratory diseases and they mediate the development and regulation of the diseases. Effective intervention targeting pulmonary VECs is of great significance for the treatment of respiratory diseas...
Autores principales: | Li, Yi-Xuan, Wang, Hong-Bo, Li, Jing, Jin, Jian-Bo, Hu, Jing-Bo, Yang, Chun-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468609/ https://www.ncbi.nlm.nih.gov/pubmed/36110525 http://dx.doi.org/10.3389/fphar.2022.983816 |
Ejemplares similares
-
Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020) -
Endothelial-Dependent and Independent Vascular Relaxation Effect of Tetrahydropalmatine on Rat Aorta
por: Zhou, Zhong-Yan, et al.
Publicado: (2019) -
Controlled in vivo Bone Formation and Vascularization Using Ultrasound-Triggered Release of Recombinant Vascular Endothelial Growth Factor From Poly(D,L-lactic-co-glycolicacid) Microbubbles
por: Gong, Yong, et al.
Publicado: (2019) -
Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications
por: Li, Zhi, et al.
Publicado: (2020) -
Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells
por: Shi, Huan, et al.
Publicado: (2020)